Go to HNE home Page HNE's Story Plan Health Community HNEDirect
Social Media Icons

Health
Disease Management Programs: Asthma

 

MANAGING EXACERBATIONS (FLARE-UPS) OF ASTHMA

 

EARLY TREATMENT OF ASTHMA EXACERBATIONS

IS THE BEST STRATEGY FOR MANAGEMENT.

 

Important components of early treatment include:

  • A written ASTHMA ACTION PLAN to guide self-management of flare-ups at home.
  • Recognition of early signs of an exacerbation, including worsening peak flow readings.
  • Appropriate use of medications.
  • Avoid and control asthma triggers. Remove triggers from your environment. Remove yourself from environments that are not free of triggers.
  • Immediate communication between you and your doctor about worsening symptoms, decreasing peak flow reading, decreased improvement after taking quick relief/rescue medication.

HOME TREATMENT

ASSESS SEVERITY

Measure peak flow level. If < 50% of personal best this suggests severe flare-up

Note the severity of your symptoms - cough, breathlessness, wheeze, and chest tightness.

 

 

INITIAL TREATMENT

Take Quick-relief/Rescue medication as prescribed.

 

 

Good Response

Mild Exacerbation

Incomplete Response

Moderate Exacerbation

Poor Response

Severe Exacerbation

Green Zone peak flow

level 80-100%

 

No wheezing or shortness of breath

 

Response to Quickrelief/

Rescue medication lasts for at least 4 hours

 

Yellow Zone peak flow

level 50-80%

 

Continue with wheezing

and shortness of breath

 

Continue to take Quickrelief/Rescue medication per your doctors instructions

 

Red Zone peak flow level <50% or personal best

 

Severe wheezing and

shortness of breath

 

Repeat Quick relief/

Rescue medication

Immediately

 

If distress is severe and

not improving, call your

doctor and proceed to

emergency department;

consider calling ambulance

or 911

 

 

NEXT STEPS

Call your doctor for

follow-up instructions

Call your doctor urgently (this day) for instructions

Go to the nearest

emergency department

 

Copyright ©2009 Health New England, Inc. • All Rights Reserved Privacy Statement and Disclaimer